These newer medications , including Semaglutide , belong to a class of drugs called GLP-1 receptor agonists . Primarily developed for controlling high blood sugar, they work by encouraging the organism to release sufficient insulin production and limiting high glucose levels. Beyond diabetes, their potential to encourage weight management has led t